StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Its Hard

<< Previous

Bullboard Posts

Next >>

Comment by Liked2Thinkon May 09, 2022 10:57am

90 Views

Post# 34666821

RE:RE:Its Hard

Its not hard to know what is coming.

I wonder if they will do a RS and then another PP right away to make it look like they are worth more and that some cluless investor will actually give them money at a perceived higher value or if they will just do the PP and then after a month do another RS. Heck maybe they will just do 5-7 more PP floats and then do the RS.

Maybe they will buy another company for $20M that makes them $400K a year but allows them to sell 5 more aristotle tests a month.

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?